XTX Topco’s Entera Bio ENTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$146K Buy
+131,622
New +$185K ﹤0.01% 2967
2025
Q4
Sell
-10,771
Closed -$20.7K 3432
2025
Q3
$20.7K Buy
+10,771
New +$20.6K ﹤0.01% 2326
2025
Q2
Sell
-10,859
Closed -$18.5K 2565
2025
Q1
$18.5K Buy
+10,859
New +$23.6K ﹤0.01% 2153
2021
Q3
Sell
-10,433
Closed -$62K 772
2021
Q2
$62K Sell
10,433
-1,126
-10% -$4.16K 0.02% 713
2021
Q1
$44K Buy
+11,559
New +$26.6K 0.02% 629

Other funds holding ENTX

XTX Topco's ENTX Position: Q1 2026 in Review

XTX Topco opened a new position in Entera Bio (ENTX) in Q1 2026: 131,622 shares worth $146K. The stake represents ﹤0.01% of the portfolio and ranks #2967 among its holdings. This is a return to the name: XTX Topco previously reported a position in ENTX as recently as Q3 2025.

XTX Topco first reported a position in ENTX in Q1 2021 and has held it in 5 quarters since. 26 funds tracked by Wall St. Rank hold ENTX as of Q1 2026.

  • XTX Topco held 131,622 shares of Entera Bio worth $146K as of Q1 2026.
  • Entera Bio was a new XTX Topco position in Q1 2026.
  • Entera Bio made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #2967 holding.
  • XTX Topco first reported a position in Entera Bio in Q1 2021 and has held it in 5 quarters since.
  • 26 funds tracked by Wall St. Rank held Entera Bio as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.